COPD Personalization: Boehringer Ingelheim's Digital Tool
Brand
Platforms
None
Services
Industries
Boehringer Ingelheim partnered with Dawn Technology to develop a digital tool that empowers COPD patients to take control of their health through personalized monitoring. The platform enables patients to track symptoms, share insights, and receive tailored support, enhancing the quality of care. By integrating real-time data, the solution helps healthcare providers deliver more customized treatment plans, improving patient outcomes and engagement. The initiative highlights the importance of technology in transforming chronic disease management, offering a scalable model for personalized healthcare delivery.
View the full case on the agency site
Original write-up, full visuals, full context.
Case study originally published by Dawn Technology:
January, 2026
?